Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio 45267-0528, USA.
Otolaryngol Head Neck Surg. 2009 Dec;141(6):727-9. doi: 10.1016/j.otohns.2009.08.026.
Post-thyroidectomy parathyroid hormone (PTH) levels have been used to predict hypocalcemia. The goal of this study was to determine whether selective supplementation for post anesthesia care unit (PACU) PTH < 15 mg/dL reduced hypocalcemia compared to observation or routine supplementation.
Controlled cohort study of thyroidectomy patients, with chart review.
Chart review of total or completion thyroidectomy patients in an academic setting.
The control group consisted of 124 subjects. The selective supplementation group consisted of 169 subjects with routine PACU PTH testing. The routine supplementation group consisted of 155 subjects with immediate postoperative calcium and vitamin D supplementation. The control group received supplementation for hypocalcemia (calcium < 8.0 mg/dL). The selective PTH group received calcium and vitamin D supplementation for PACU PTH < 15 mg/dL or hypocalcemia. The routine supplementation group received oral calcium and calcitriol supplementation immediately after surgery. Four separate postoperative day 1 (POD1) outcome measures were evaluated: 1) mean serum calcium; 2) rate of hypocalcemia < 8 mg/dL; 3) rate of significant hypocalcemia < 7.5 mg/dL; and 4) rate of hypercalcemia > 10 mg/dL.
Mean serum calcium was lower and the rate of hypocalcemia was higher in the control group than the selective PACU PTH group on POD1 (8.2 vs 8.6 mg/dL, P < 0.0001, and 35% vs 14%, P < 0.0001, respectively). Mean serum calcium was higher (8.9 vs 8.6 mg/dL, P < 0.0001) and the rate of hypocalcemia lower in the routine supplementation group than in the selective group. However, the rate of hypercalcemia was higher in the routine supplementation group than in the selective group (4.5% vs 0%, P = 0.006).
Routine PTH testing and supplementation for patients with hypoparathyroidism reduced the proportion of patients experiencing hypocalcemia. However, supplementation for intraoperative PTH < 15 mg/dL had a higher rate of hypocalcemia than routine supplementation, but with a lower rate of hypercalcemia.
甲状旁腺激素(PTH)水平在甲状腺切除术后用于预测低钙血症。本研究的目的是确定与观察或常规补充相比,选择性补充术后麻醉护理单元(PACU)PTH<15mg/dL 是否可降低低钙血症的发生率。
甲状腺切除术患者的对照队列研究,进行图表回顾。
学术环境下的甲状腺全部或部分切除术患者的图表回顾。
对照组由 124 名患者组成。选择性补充组由 169 名常规 PACU PTH 检测患者组成。常规补充组由 155 名术后立即补充钙和维生素 D 的患者组成。对照组接受低钙血症(钙<8.0mg/dL)的补充。选择性 PTH 组在 PACU PTH<15mg/dL 或低钙血症时接受钙和维生素 D 补充。常规补充组在手术后立即口服补充钙和骨化三醇。评估了四个独立的术后第 1 天(POD1)的结果测量:1)平均血清钙;2)低钙血症发生率<8mg/dL;3)显著低钙血症发生率<7.5mg/dL;4)高钙血症发生率>10mg/dL。
与选择性 PACU PTH 组相比,对照组在 POD1 时的平均血清钙水平较低(8.2 与 8.6mg/dL,P<0.0001),低钙血症发生率较高(35%与 14%,P<0.0001)。常规补充组的平均血清钙水平较高(8.9 与 8.6mg/dL,P<0.0001),低钙血症发生率较低。然而,常规补充组的高钙血症发生率高于选择性组(4.5%与 0%,P=0.006)。
常规甲状旁腺激素检测和补充对甲状旁腺功能减退症患者可降低低钙血症的发生率。然而,术中 PTH<15mg/dL 时补充的低钙血症发生率高于常规补充,但高钙血症的发生率较低。